Avoro Capital Advisors LLC 13D and 13G filings for Kymera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 09:30 am Purchase | 2024-09-30 | 13G | Kymera Therapeutics, Inc. KYMR | Avoro Capital Advisors LLC | 7,750,000 9.990% | 3,975,000 (+105.30%) | Filing |
| 2024-02-14 09:15 am Sale | 2023-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | Avoro Capital Advisors LLC | 3,775,000 6.800% | -75,000 (-1.95%) | Filing |
| 2023-02-14 09:37 am Purchase | 2022-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | Avoro Capital Advisors LLC | 3,850,000 7.000% | 3,850,000 (New Position) | Filing |